CABP Clinical Response Endpoint Gets A Boost At Ceftaroline Advisory Panel
This article was originally published in The Pink Sheet Daily
Executive Summary
Panel unanimously supports Forest's antibiotic for community-acquired bacterial pneumonia - as well the method of demonstrating the product's efficacy.